Biotech Showcase™ 2017: Chinese capital accesses Western innovation to create homegrown industry

January 24, 2017
With the Chinese market growing at 10–15% a year, it is poised to be world’s largest by 2026. Tony Chu, co-founder and managing partner at consultants TPP Healthcare, explains to Mike Ward, global director of content at Informa Pharma Intelligence’s insights portfolio, how Chinese capital is accessing Western innovation to build a PRC pharma industry.
Previous Video
Biotech Showcase™ 2017: ProNAI defects from oligos to DDR as Sierra Oncology
Biotech Showcase™ 2017: ProNAI defects from oligos to DDR as Sierra Oncology

Sierra Oncology president and CEO Dr. Nick Glover tells Mike Ward, Informa Pharma Intelligence insight glob...

Next Video
Biotech Showcase™ 2017: Advancing neurokinin receptor antagonists in respiratory and women’s health
Biotech Showcase™ 2017: Advancing neurokinin receptor antagonists in respiratory and women’s health

Starting the year with a cash injection of GDP 23 million, 2012 GSK spin-out NeRRe Therapeutics intends to ...